GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curexo Inc (XKRX:060280) » Definitions » Cyclically Adjusted PB Ratio

Curexo (XKRX:060280) Cyclically Adjusted PB Ratio : 4.71 (As of Jun. 04, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Curexo Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Curexo's current share price is ₩9930.00. Curexo's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩2,108.46. Curexo's Cyclically Adjusted PB Ratio for today is 4.71.

The historical rank and industry rank for Curexo's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:060280' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.93   Med: 4.75   Max: 13.09
Current: 4.43

During the past years, Curexo's highest Cyclically Adjusted PB Ratio was 13.09. The lowest was 1.93. And the median was 4.75.

XKRX:060280's Cyclically Adjusted PB Ratio is ranked worse than
76.81% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs XKRX:060280: 4.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Curexo's adjusted book value per share data for the three months ended in Mar. 2025 was ₩2,301.123. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,108.46 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Curexo Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Curexo's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curexo Cyclically Adjusted PB Ratio Chart

Curexo Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.93 4.50 3.85 9.80 3.12

Curexo Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.95 4.95 3.78 3.12 3.78

Competitive Comparison of Curexo's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Curexo's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curexo's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Curexo's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Curexo's Cyclically Adjusted PB Ratio falls into.


;
;

Curexo Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Curexo's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=9930.00/2108.46
=4.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curexo's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Curexo's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2301.123/122.5900*122.5900
=2,301.123

Current CPI (Mar. 2025) = 122.5900.

Curexo Quarterly Data

Book Value per Share CPI Adj_Book
201506 1,339.437 100.051 1,641.184
201509 1,359.163 100.111 1,664.354
201512 1,199.280 100.220 1,466.964
201603 1,062.483 100.561 1,295.233
201606 921.600 100.791 1,120.926
201609 773.735 101.461 934.862
201612 2,615.515 101.561 3,157.069
201703 2,394.821 102.851 2,854.442
201706 2,284.217 102.611 2,728.960
201709 2,458.247 103.491 2,911.924
201712 2,327.424 102.991 2,770.334
201803 2,835.986 104.101 3,339.682
201806 2,655.549 104.130 3,126.311
201809 2,503.551 105.651 2,904.958
201812 2,099.382 104.351 2,466.330
201903 1,896.368 104.491 2,224.842
201906 1,684.353 104.881 1,968.755
201909 1,448.763 105.200 1,688.245
201912 1,318.462 105.121 1,537.560
202003 1,296.988 105.354 1,509.173
202006 1,270.347 105.112 1,481.583
202009 1,289.083 106.198 1,488.063
202012 1,341.038 105.765 1,554.363
202103 1,300.587 107.357 1,485.126
202106 1,327.337 107.579 1,512.552
202109 1,294.917 108.759 1,459.590
202112 1,282.599 109.676 1,433.616
202203 1,270.787 111.848 1,392.835
202206 2,447.320 114.072 2,630.060
202209 2,130.321 114.715 2,276.558
202212 2,099.379 115.179 2,234.456
202303 2,302.460 116.507 2,422.666
202306 2,431.991 117.182 2,544.226
202309 2,452.810 118.964 2,527.580
202312 2,452.109 118.837 2,529.547
202403 2,472.356 120.123 2,523.127
202406 2,438.822 120.007 2,491.308
202409 2,403.491 120.861 2,437.871
202412 2,272.591 121.135 2,299.884
202503 2,301.123 122.590 2,301.123

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Curexo  (XKRX:060280) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Curexo Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Curexo's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Curexo Business Description

Traded in Other Exchanges
N/A
Address
Pangyo Seven Venture Valley Building, 3 Dong 10th Floor Sampyeong-dong, Seongnam-si, KOR, 463-400
Curexo Inc is a South Korea based company engages in the distribution of medical equipment including Magnetic Resonance Imaging (MRI), endoscopy, and others. It has developed medical devices such as the surgical device for breast cancer and drug delivery technologies.

Curexo Headlines

No Headlines